<?xml version='1.0' encoding='utf-8'?>
<document id="28065859"><sentence text="Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia."><entity charOffset="59-68" id="DDI-PubMed.28065859.s1.e0" text="lapatinib" /><entity charOffset="70-79" id="DDI-PubMed.28065859.s1.e1" text="pazopanib" /><entity charOffset="81-92" id="DDI-PubMed.28065859.s1.e2" text="regorafenib" /><entity charOffset="97-106" id="DDI-PubMed.28065859.s1.e3" text="sorafenib" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e0" e2="DDI-PubMed.28065859.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e0" e2="DDI-PubMed.28065859.s1.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e0" e2="DDI-PubMed.28065859.s1.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e0" e2="DDI-PubMed.28065859.s1.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e1" e2="DDI-PubMed.28065859.s1.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e1" e2="DDI-PubMed.28065859.s1.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e1" e2="DDI-PubMed.28065859.s1.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e2" e2="DDI-PubMed.28065859.s1.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s1.e2" e2="DDI-PubMed.28065859.s1.e3" /></sentence><sentence text="Kinase inhibitors (KIs) are a rapidly expanding class of drugs used primarily for the treatment of cancer" /><sentence text=" Data relating to the inhibition of UDP-glucuronosyltransferase (UGT) enzymes by KIs is sparse" /><sentence text=" However, lapatinib (LAP), pazopanib (PAZ), regorafenib (REG) and sorafenib (SOR) have been implicated in the development of hyperbilirubinemia in patients"><entity charOffset="10-19" id="DDI-PubMed.28065859.s4.e0" text="lapatinib" /><entity charOffset="21-24" id="DDI-PubMed.28065859.s4.e1" text="LAP" /><entity charOffset="27-36" id="DDI-PubMed.28065859.s4.e2" text="pazopanib" /><entity charOffset="38-41" id="DDI-PubMed.28065859.s4.e3" text="PAZ" /><entity charOffset="44-55" id="DDI-PubMed.28065859.s4.e4" text="regorafenib" /><entity charOffset="57-60" id="DDI-PubMed.28065859.s4.e5" text="REG" /><entity charOffset="66-75" id="DDI-PubMed.28065859.s4.e6" text="sorafenib" /><entity charOffset="77-80" id="DDI-PubMed.28065859.s4.e7" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e0" e2="DDI-PubMed.28065859.s4.e7" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e1" e2="DDI-PubMed.28065859.s4.e7" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e2" e2="DDI-PubMed.28065859.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e2" e2="DDI-PubMed.28065859.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e2" e2="DDI-PubMed.28065859.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e2" e2="DDI-PubMed.28065859.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e2" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e2" e2="DDI-PubMed.28065859.s4.e7" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e3" e2="DDI-PubMed.28065859.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e3" e2="DDI-PubMed.28065859.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e3" e2="DDI-PubMed.28065859.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e3" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e3" e2="DDI-PubMed.28065859.s4.e7" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e4" e2="DDI-PubMed.28065859.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e4" e2="DDI-PubMed.28065859.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e4" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e4" e2="DDI-PubMed.28065859.s4.e7" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e5" e2="DDI-PubMed.28065859.s4.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e5" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e5" e2="DDI-PubMed.28065859.s4.e7" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e6" e2="DDI-PubMed.28065859.s4.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s4.e6" e2="DDI-PubMed.28065859.s4.e7" /></sentence><sentence text=" This study aimed to characterise the role of UGT1A1 inhibition in hyperbilirubinemia and assess the broader potential of these drugs to perpetrate drug-drug interactions arising from UGT enzyme inhibition" /><sentence text=" Twelve recombinant human UGTs from subfamilies 1A and 2B were screened for inhibition by LAP, PAZ, REG and SOR"><entity charOffset="90-92" id="DDI-PubMed.28065859.s6.e0" text="LAP" /><entity charOffset="95-97" id="DDI-PubMed.28065859.s6.e1" text="PAZ" /><entity charOffset="100-102" id="DDI-PubMed.28065859.s6.e2" text="REG" /><entity charOffset="108-110" id="DDI-PubMed.28065859.s6.e3" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e0" e2="DDI-PubMed.28065859.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e0" e2="DDI-PubMed.28065859.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e0" e2="DDI-PubMed.28065859.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e0" e2="DDI-PubMed.28065859.s6.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e1" e2="DDI-PubMed.28065859.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e1" e2="DDI-PubMed.28065859.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e1" e2="DDI-PubMed.28065859.s6.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e2" e2="DDI-PubMed.28065859.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s6.e2" e2="DDI-PubMed.28065859.s6.e3" /></sentence><sentence text=" IC50 values for the inhibition of all UGT1A enzymes, except UGT1A3 and UGT1A4, by the four KIs were &lt;10μM" /><sentence text=" LAP, PAZ, REG and SOR inhibited UGT1A1-catalysed bilirubin glucuronidation with mean IC50 values ranging from 34nM (REG) to 3734nM (PAZ)"><entity charOffset="50-59" id="DDI-PubMed.28065859.s8.e0" text="bilirubin" /><entity charOffset="1-9" id="DDI-PubMed.28065859.s8.e1" text="LAP" /><entity charOffset="6-14" id="DDI-PubMed.28065859.s8.e2" text="PAZ" /><entity charOffset="133-141" id="DDI-PubMed.28065859.s8.e3" text="PAZ" /><entity charOffset="11-19" id="DDI-PubMed.28065859.s8.e4" text="REG" /><entity charOffset="117-125" id="DDI-PubMed.28065859.s8.e5" text="REG" /><entity charOffset="19-27" id="DDI-PubMed.28065859.s8.e6" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e1" e2="DDI-PubMed.28065859.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e2" e2="DDI-PubMed.28065859.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e2" e2="DDI-PubMed.28065859.s8.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e2" e2="DDI-PubMed.28065859.s8.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e2" e2="DDI-PubMed.28065859.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e2" e2="DDI-PubMed.28065859.s8.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e2" e2="DDI-PubMed.28065859.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e4" e2="DDI-PubMed.28065859.s8.e4" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e4" e2="DDI-PubMed.28065859.s8.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e4" e2="DDI-PubMed.28065859.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e4" e2="DDI-PubMed.28065859.s8.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e4" e2="DDI-PubMed.28065859.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e6" e2="DDI-PubMed.28065859.s8.e6" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e6" e2="DDI-PubMed.28065859.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e6" e2="DDI-PubMed.28065859.s8.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e6" e2="DDI-PubMed.28065859.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e0" e2="DDI-PubMed.28065859.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e0" e2="DDI-PubMed.28065859.s8.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e0" e2="DDI-PubMed.28065859.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e5" e2="DDI-PubMed.28065859.s8.e5" /><pair ddi="false" e1="DDI-PubMed.28065859.s8.e5" e2="DDI-PubMed.28065859.s8.e3" /></sentence><sentence text=" Subsequent kinetic experiments confirmed that REG and SOR were very potent inhibitors of human liver microsomal β-estradiol glucuronidation, an established surrogate for bilirubin glucuronidation, with mean Ki values of 20 and 33nM, respectively"><entity charOffset="171-180" id="DDI-PubMed.28065859.s9.e0" text="bilirubin" /><entity charOffset="47-55" id="DDI-PubMed.28065859.s9.e1" text="REG" /><entity charOffset="55-63" id="DDI-PubMed.28065859.s9.e2" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s9.e1" e2="DDI-PubMed.28065859.s9.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s9.e1" e2="DDI-PubMed.28065859.s9.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s9.e1" e2="DDI-PubMed.28065859.s9.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s9.e2" e2="DDI-PubMed.28065859.s9.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s9.e2" e2="DDI-PubMed.28065859.s9.e0" /></sentence><sentence text=" Ki values for LAP and PAZ were approximately 1- and 2-orders of magnitude higher than those for REG and SOR"><entity charOffset="15-17" id="DDI-PubMed.28065859.s10.e0" text="LAP" /><entity charOffset="23-25" id="DDI-PubMed.28065859.s10.e1" text="PAZ" /><entity charOffset="97-99" id="DDI-PubMed.28065859.s10.e2" text="REG" /><entity charOffset="105-107" id="DDI-PubMed.28065859.s10.e3" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e0" e2="DDI-PubMed.28065859.s10.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e0" e2="DDI-PubMed.28065859.s10.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e0" e2="DDI-PubMed.28065859.s10.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e0" e2="DDI-PubMed.28065859.s10.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e1" e2="DDI-PubMed.28065859.s10.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e1" e2="DDI-PubMed.28065859.s10.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e1" e2="DDI-PubMed.28065859.s10.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e2" e2="DDI-PubMed.28065859.s10.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s10.e2" e2="DDI-PubMed.28065859.s10.e3" /></sentence><sentence text=" REG and SOR were equipotent inhibitors of human liver microsomal UGT1A9 (mean Ki 678nM)"><entity charOffset="1-3" id="DDI-PubMed.28065859.s11.e0" text="REG" /><entity charOffset="9-11" id="DDI-PubMed.28065859.s11.e1" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s11.e0" e2="DDI-PubMed.28065859.s11.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s11.e0" e2="DDI-PubMed.28065859.s11.e1" /></sentence><sentence text=" REG and SOR are the most potent inhibitors of a human UGT enzyme identified to date"><entity charOffset="1-3" id="DDI-PubMed.28065859.s12.e0" text="REG" /><entity charOffset="9-11" id="DDI-PubMed.28065859.s12.e1" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s12.e0" e2="DDI-PubMed.28065859.s12.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s12.e0" e2="DDI-PubMed.28065859.s12.e1" /></sentence><sentence text=" In vitro-in vivo extrapolation indicates that inhibition of UGT1A1 contributes significantly to the hyperbilirubinemia observed in patients treated with REG and SOR, but not with LAP and PAZ"><entity charOffset="180-182" id="DDI-PubMed.28065859.s13.e0" text="LAP" /><entity charOffset="188-190" id="DDI-PubMed.28065859.s13.e1" text="PAZ" /><entity charOffset="154-156" id="DDI-PubMed.28065859.s13.e2" text="REG" /><entity charOffset="162-164" id="DDI-PubMed.28065859.s13.e3" text="SOR" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e2" e2="DDI-PubMed.28065859.s13.e2" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e2" e2="DDI-PubMed.28065859.s13.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e2" e2="DDI-PubMed.28065859.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e2" e2="DDI-PubMed.28065859.s13.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e3" e2="DDI-PubMed.28065859.s13.e3" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e3" e2="DDI-PubMed.28065859.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e3" e2="DDI-PubMed.28065859.s13.e1" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e0" e2="DDI-PubMed.28065859.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28065859.s13.e0" e2="DDI-PubMed.28065859.s13.e1" /></sentence><sentence text=" Inhibition of other UGT1A1 substrates in vivo is likely" /><sentence text="" /></document>